Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060523822> ?p ?o ?g. }
- W2060523822 endingPage "e1116" @default.
- W2060523822 startingPage "e1104" @default.
- W2060523822 abstract "BACKGROUND: Quantifying pediatric immunologic recovery by highly active antiretroviral therapy (HAART) initiation at different CD4 percentage (CD4%) and age thresholds may inform decisions about timing of treatment initiation. METHODS: HIV-1-infected, HAART-naive children in Europe and the Americas were followed from 2002 through 2009 in PENPACT-1. Data from 162 vertically infected children, with at least World Health Organization “mild” immunosuppression and CD4% <10th percentile, were analyzed for improvement to a normal CD4% (≥10th percentile) within 4 years after HAART initiation. Data from 209 vertically infected children, regardless of immune status, were analyzed for CD4% outcomes at 4 years and viral failure within 4 years. RESULTS: Seventy-two percent of baseline immunosuppressed children recovered to normal within 4 years. Compared with “severe” immunosuppression, more children with “mild” immunosuppression (difference 36%, 95% confidence interval [CI]: 22% to 49%) or “advanced” immunosuppression (difference 20.8%, 95% CI: 5.8% to 35.9%) recovered a normal CD4%. For each 5-year increase in baseline age, the proportion of children achieving a normal CD4% declined by 19% (95% CI: 11% to 27%). Combining baseline CD4% and age effects resulted in >90% recovery when initiating HAART with “mild” immunosuppression at any age or “advanced” immunosuppression at age <3 years. Baseline CD4% effects became greater with increasing age (P = .02). At 4 years, most immunologic benefits were still significant but diminished. Viral failure was highest in infancy (56%) and adolescence (63%). CONCLUSIONS: Initiating HAART at higher CD4% and younger ages maximizes potential for immunologic recovery. Guidelines should weigh immunologic benefits against long-term risks." @default.
- W2060523822 created "2016-06-24" @default.
- W2060523822 creator A5005617480 @default.
- W2060523822 creator A5019413838 @default.
- W2060523822 creator A5024514589 @default.
- W2060523822 creator A5041448743 @default.
- W2060523822 creator A5042081819 @default.
- W2060523822 creator A5056245742 @default.
- W2060523822 creator A5059702702 @default.
- W2060523822 creator A5065389512 @default.
- W2060523822 creator A5066456906 @default.
- W2060523822 creator A5071879780 @default.
- W2060523822 creator A5090886913 @default.
- W2060523822 creator A5091232774 @default.
- W2060523822 date "2014-10-01" @default.
- W2060523822 modified "2023-10-17" @default.
- W2060523822 title "Using CD4 Percentage and Age to Optimize Pediatric Antiretroviral Therapy Initiation" @default.
- W2060523822 cites W1484620035 @default.
- W2060523822 cites W1494122660 @default.
- W2060523822 cites W1558056931 @default.
- W2060523822 cites W1588713146 @default.
- W2060523822 cites W1596626870 @default.
- W2060523822 cites W1627837721 @default.
- W2060523822 cites W1767940945 @default.
- W2060523822 cites W1967884667 @default.
- W2060523822 cites W1970334460 @default.
- W2060523822 cites W1981382757 @default.
- W2060523822 cites W1987876529 @default.
- W2060523822 cites W1990124190 @default.
- W2060523822 cites W2005006791 @default.
- W2060523822 cites W2012377587 @default.
- W2060523822 cites W2015052593 @default.
- W2060523822 cites W2019756661 @default.
- W2060523822 cites W2020671331 @default.
- W2060523822 cites W2040059881 @default.
- W2060523822 cites W2040816861 @default.
- W2060523822 cites W2054258978 @default.
- W2060523822 cites W2061912088 @default.
- W2060523822 cites W2064554628 @default.
- W2060523822 cites W2083281375 @default.
- W2060523822 cites W2086310869 @default.
- W2060523822 cites W2091122934 @default.
- W2060523822 cites W2093979189 @default.
- W2060523822 cites W2097345834 @default.
- W2060523822 cites W2101828653 @default.
- W2060523822 cites W2105213363 @default.
- W2060523822 cites W2112470549 @default.
- W2060523822 cites W2112669742 @default.
- W2060523822 cites W2122986037 @default.
- W2060523822 cites W2129488246 @default.
- W2060523822 cites W2130316654 @default.
- W2060523822 cites W2137635384 @default.
- W2060523822 cites W2143265231 @default.
- W2060523822 cites W2144275513 @default.
- W2060523822 cites W2146327796 @default.
- W2060523822 cites W2152505869 @default.
- W2060523822 cites W2153787696 @default.
- W2060523822 cites W2157493438 @default.
- W2060523822 cites W2157524492 @default.
- W2060523822 cites W2168039974 @default.
- W2060523822 cites W2170988154 @default.
- W2060523822 cites W2331936027 @default.
- W2060523822 cites W2339219218 @default.
- W2060523822 cites W4294553991 @default.
- W2060523822 doi "https://doi.org/10.1542/peds.2014-0527" @default.
- W2060523822 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4179097" @default.
- W2060523822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25266426" @default.
- W2060523822 hasPublicationYear "2014" @default.
- W2060523822 type Work @default.
- W2060523822 sameAs 2060523822 @default.
- W2060523822 citedByCount "13" @default.
- W2060523822 countsByYear W20605238222015 @default.
- W2060523822 countsByYear W20605238222016 @default.
- W2060523822 countsByYear W20605238222017 @default.
- W2060523822 countsByYear W20605238222019 @default.
- W2060523822 countsByYear W20605238222020 @default.
- W2060523822 countsByYear W20605238222022 @default.
- W2060523822 countsByYear W20605238222023 @default.
- W2060523822 crossrefType "journal-article" @default.
- W2060523822 hasAuthorship W2060523822A5005617480 @default.
- W2060523822 hasAuthorship W2060523822A5019413838 @default.
- W2060523822 hasAuthorship W2060523822A5024514589 @default.
- W2060523822 hasAuthorship W2060523822A5041448743 @default.
- W2060523822 hasAuthorship W2060523822A5042081819 @default.
- W2060523822 hasAuthorship W2060523822A5056245742 @default.
- W2060523822 hasAuthorship W2060523822A5059702702 @default.
- W2060523822 hasAuthorship W2060523822A5065389512 @default.
- W2060523822 hasAuthorship W2060523822A5066456906 @default.
- W2060523822 hasAuthorship W2060523822A5071879780 @default.
- W2060523822 hasAuthorship W2060523822A5090886913 @default.
- W2060523822 hasAuthorship W2060523822A5091232774 @default.
- W2060523822 hasBestOaLocation W20605238222 @default.
- W2060523822 hasConcept C105795698 @default.
- W2060523822 hasConcept C122048520 @default.
- W2060523822 hasConcept C126322002 @default.
- W2060523822 hasConcept C142462285 @default.
- W2060523822 hasConcept C187212893 @default.
- W2060523822 hasConcept C203014093 @default.